Abbott Laboratories
Abbott Laboratories is an American company specializing in diversified healthcare products, including medical devices, nutritional products, and diagnostics.
Price history of Abbott Laboratories
Price history of Abbott Laboratories
Performance & Momentum
Abbott acquires Exact Sciences in $21B deal
Abbott Laboratories announced its strategic acquisition of Exact Sciences, a leader in colorectal cancer screening, for approximately $21 billion. This move significantly strengthens its diagnostics business, a rapidly growing sector. Expert Jim Cramer called the acquisition "very important," highlighting it as a compelling buy opportunity that reflects strong confidence in Abbott's growth potential. Additionally, speculation around U.S. interest rate cuts supports a positive outlook for the healthcare sector.
Strategic Analysis
Abbott Laboratories • 2026
Abbott Laboratories is a diversified healthcare group that combines medical devices, diagnostics, nutrition, and a more focused biotechnology business. This diversification helps smooth out the cycles specific to each segment while relying on strong positions in high-value niches, notably monitoring and treatment devices. Its status as a regular dividend payer enhances its appeal as a long-term defensive investment.
- Diversified business model that reduces dependence on a single healthcare activity
- Strong positioning in defensive and recurring markets such as medical devices and diagnostics
- Appeal to long-term investors thanks to a robust dividend culture
- Recent pressure on share performance, suggesting more cautious market expectations
- Dependence on reimbursement dynamics, medical innovation, and competition in devices
Momentum appears moderate and remains in a recovery phase after a period of marked underperformance over recent horizons. The trend reflects a defensive quality profile that is still being penalized by the market, but it retains upside potential if operational execution stabilizes and the strongest segments continue to support growth. For a retail investor, the case remains more oriented toward resilience and income than toward immediate share price acceleration.
Similar stocks to Abbott Laboratories
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
